Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 8Sanofi-Aventis Canada Inc.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Brand Name : APIDRA (3mL OptiSet)
Patent Number : 2441260
Filing Date : 2002-03-09
Strength per Unit : 100 U / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Brand Name : APIDRA
Patent Number : 2441260
Filing Date : 2002-03-09
Strength per Unit : 100 U / mL (3mL Cartridge)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Brand Name : APIDRA
Patent Number : 2441260
Filing Date : 2002-03-09
Strength per Unit : 100 U / mL (10 mL Vial)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Brand Name : APIDRA
Patent Number : 2441260
Filing Date : 2002-03-09
Strength per Unit : 100 U / mL (3mL Solostar)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2022-03-09
Date Granted : 2011-04-26
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
Brand Name : APIDRA (3mL OptiSet)
Patent Number : 2235443
Filing Date : 1998-06-18
Strength per Unit : 100 U / mL
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
Brand Name : APIDRA
Patent Number : 2235443
Filing Date : 1998-06-18
Strength per Unit : 100 U / mL (3mL Cartridge)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
Brand Name : APIDRA
Patent Number : 2235443
Filing Date : 1998-06-18
Strength per Unit : 100 U / mL (10 mL Vial)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
Brand Name : APIDRA
Patent Number : 2235443
Filing Date : 1998-06-18
Strength per Unit : 100 U / mL (3mL Solostar)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2018-06-18
Date Granted : 2011-11-01
LOOKING FOR A SUPPLIER?